amlodipine has been researched along with ADPKD in 4 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The renoprotective effect of candesartan is considered more favorable than amlodipine in the treatment of ADPKD." | 5.11 | Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease. ( Higaki, Y; Higashihara, E; Horie, S; Hosoya, T; Kamura, K; Mochizuki, T; Nakayama, T; Nutahara, K; Shimizu, T; Tsuchiya, K; Yamamoto, N, 2005) |
| "In conclusion, left ventricular hypertrophy, a major cardiovascular risk factor, was decreased to a significantly greater extent by rigorous than standard BP control." | 2.70 | Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. ( Brosnahan, G; Chapman, A; Ecder, T; Edelstein, C; Johnson, A; McFann, K; Schrier, R; Tison, L, 2002) |
| "Although proteinuria has been considered a surrogate of renal disease progression, further studies will be necessary to confirm this hypothesis in ADPKD, because after 5 years, no differences in renal function were observed between the enalapril and amlodipine groups." | 2.69 | Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. ( Brosnahan, GM; Chapman, AB; Ecder, T; Edelstein, CL; Johnson, AM; Schrier, RW, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, Y | 1 |
| Okada, H | 1 |
| Moriwaki, K | 1 |
| Nagao, S | 1 |
| Takahashi, H | 1 |
| Suzuki, H | 1 |
| Nutahara, K | 1 |
| Higashihara, E | 1 |
| Horie, S | 1 |
| Kamura, K | 1 |
| Tsuchiya, K | 1 |
| Mochizuki, T | 1 |
| Hosoya, T | 1 |
| Nakayama, T | 1 |
| Yamamoto, N | 1 |
| Higaki, Y | 1 |
| Shimizu, T | 1 |
| Ecder, T | 2 |
| Chapman, AB | 1 |
| Brosnahan, GM | 1 |
| Edelstein, CL | 1 |
| Johnson, AM | 1 |
| Schrier, RW | 1 |
| Schrier, R | 1 |
| McFann, K | 1 |
| Johnson, A | 1 |
| Chapman, A | 1 |
| Edelstein, C | 1 |
| Brosnahan, G | 1 |
| Tison, L | 1 |
3 trials available for amlodipine and ADPKD
| Article | Year |
|---|---|
Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphe | 2005 |
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Ch | 2000 |
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Creatinine; Echocardiography; Enalapril; | 2002 |
1 other study available for amlodipine and ADPKD
| Article | Year |
|---|---|
The effects of antihypertensive agents on the survival rate of polycystic kidney disease in Han:SPRD rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Body Weight; Kidney; Kid | 2002 |